A guide to the extrapyramidal side-effects of antipsychotic drugs /

Mostrar otras versiones (1)

Antipsychotic drugs have revolutionised the management of major psychiatric disorders and the outcomes of those who suffer from them. They are, however, possessed of a range of adverse effects, amongst the most frequent and distressing of which are those resulting in disturbance of voluntary motor f...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Owens, D. G. Cunningham (David Griffith Cunningham), 1949-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge ; New York : Cambridge University Press, 1999.
Temas:
Extrapyramidal disorders.
Antipsychotic drugs > Side effects.
Basal Ganglia Diseases > diagnosis
Basal Ganglia Diseases > drug therapy
Antipsychotic Agents > adverse effects
Extrapyramidal Tracts > drug effects
Syndrome extrapyramidal.
Neuroleptiques > Effets secondaires.
HEALTH & FITNESS > Diseases > Alzheimer's & Dementia.
MEDICAL > Neurology.
Antipsychotic drugs > Side effects
Extrapyramidal disorders
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Preface
  • 1 The background
  • Introduction
  • The Golden Age
  • The chlorpromazine story
  • In the wake of chlorpromazine
  • Practice, theory and names
  • 'Typicality' versus 'atypicality'
  • 2 Some preliminaries
  • The need for vigilance
  • The classification of drug-related movement disorders
  • The villains of the piece
  • A small caveat
  • 3 Acute dystonias
  • Introduction
  • The concept of dystonia
  • Clinical features
  • Diagnosis
  • Epidemiology
  • Predisposing factors
  • Onset, course and outcome
  • Treatment
  • Pathophysiology.
  • Addendum: acute dystonias and oculogyric crises
  • 4 Parkinsonism
  • Introduction
  • Terminology
  • Clinical features
  • Diagnosis
  • Epidemiology
  • Predisposing factors
  • Onset, course and outcome
  • Treatment
  • Pathophysiology
  • 5 Akathisia
  • Introduction
  • Terminology and concepts
  • Clinical features
  • Modifying factors
  • Diagnosis
  • Epidemiology
  • Predisposing factors
  • Onset, course and outcome
  • Treatment
  • Pathophysiology
  • 6 Tardive dyskinesia
  • Introduction
  • The concept of tardive dyskinesia
  • Clinical features
  • Operationalised criteria for tardive dyskinesia.
  • Modifying factors
  • Diagnosis
  • Epidemiology
  • Predisposing factors
  • Onset, course and outcome
  • Treatment
  • Pathophysiology
  • Clinical subtypes
  • 7 Tardive and chronic dystonia
  • Introduction
  • Definition and classification of chronic dystonia
  • Clinical features
  • Characteristics of dystonia
  • Diagnosis
  • Epidemiology
  • Predisposing factors
  • Onset, course and outcome
  • Treatment
  • 8 Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?
  • Introduction
  • The descriptive evidence
  • The Shenley Study.
  • The limitations of the concept of tardive dyskinesia
  • 9 Special populations
  • Children and adolescents
  • Learning disability
  • The elderly
  • Acquired immune deficiency syndrome
  • 10 The clinical examination
  • Introduction
  • Preliminaries
  • The standardised examination
  • 11 An overview of some standardised recording instruments
  • Introduction
  • The origins of rating scales for movement disorders
  • Principles involved in rating scales
  • Standardised rating scales for Parkinson's disease
  • Standardised rating scales for drug-related parkinsonism.
  • Standardised rating scales for tardive dyskinesia
  • Standardised rating scales for akathisia
  • Standardised rating scales for dystonia
  • Combined rating scales
  • Learning disability
  • Some general issues
  • The choice of scale
  • 12 Some medicolegal and quality-of-care issues
  • Introduction
  • 'Informing' consent
  • The medicolegal dimension
  • New drugs for old?
  • Some practical suggestions
  • References
  • Index.

Ejemplares similares